Ferrante ND, Hubbard RA, Weinfurtner K, Mezina AI, Newcomb CW, Furth EE, Bhattacharya D, Njei B, Taddei TH, Singal A, Hoteit MA, Park LS, Kaplan D, Lo Re V 3rd. Validity of Diagnostic Codes and Laboratory Tests to Identify Cholangiocarcinoma and Its Subtypes , Pharmacoepidemiol Drug Saf: 2025

Kappus MR, Hughes D, Ganger D, Kim Y, Bashir M, Bonn J, Borhani A, Fetzer D, Fischer R, Gabriel H, Guindi M, Hecht E, Hoteit M, Khanna G, Krasuski R, Lewis S, Mavis A, Miller F, Morin C, Schiano T, Schooler G, Shingina A, Sirlin C, Singal A, Taouli B, Tompkins R, Zaidi A, VanWagner L, Yokoo T. A survey of national practice patterns of hepatocellular carcinoma surveillance for patients with fontan-associated liver disease: A call to action , Liver Transpl: 2025

Singal AG, Yang JD, Jalal PK, Salgia R, Mehta N, Hoteit MA, Kao K, Daher D, El Dahan KS, Hernandez P, Nayak A, Kim N, Pham S, Gamez J, Troost JP, Parikh ND. Patient-perceived risk of HCC and net benefit of surveillance: A multi-center survey study , Am J Gastroenterol: 2025

Hoteit MA, Weinfurtner K. Recurrent HCC after liver transplantation: Small steps, while awaiting a breakthrough , Liver Transpl, 31: 2025,421-422

Kim YY, Nyman A, Huang YS, Tomlinson AZ, McRae MP, Everson GT, Vaikunth S, Rosenthal B, Rychik J, Hoteit MA. Alterations in Liver Perfusion in Adults With Fontan Circulation as Assessed by Dual Cholate Clearance , J Am Heart Assoc: 2025

Rosenthal BE, Hoteit MA, Lluri G, Haeffele C, Daugherty T, Krasuski RA, Serfas JD, de Freitas RA, Porlier A, Lubert AM, Wu FM, Valente AM, Krieger EV, Buber Y, Rodriguez FH 3rd, Gaignard S, Saraf A, Hindes M, Earing MG, Lewis MJ, Rosenbaum MS, Zaidi AN, Hopkins K, Bradley EA, Cedars AM, Ko JL, Franklin WJ, Frederickson A, Ginde S, Grewal J, Nyman A, Min J, Schluger C, Rand E, Hilscher M, Rychik J, Kim YY. Characteristics and Survival Outcomes of Hepatocellular Carcinoma After the Fontan Operation , JACC Adv, 4: 2025,101646

Xu E, Tabrizian P, Gutierrez J, Hoteit M, Ghaziani T, Zhou K, Parikh N, Ajmera V, Aby E, Shui A, Marino R, Martin A, Wong C, Kao K, Dave S, Florman S, Yao F, Mehta N. Downstaging of hepatocellular carcinoma before liver transplantation: Results from a national multicenter prospective cohort study , Hepatology: 2025

Taj R, Ng K, Cuddapah SR, Rand EB, Bleicher M, Amaral S, Hoteit MA, Reddy RK, Feyssa E, Furth EE, Olthoff KM, Abu-Gazala S, Levine MH, Vyas F, Abt PL. Liver Transplant From a Deceased Donor With Cystinosis: A Case Report , JIMD Rep, 66: 2025,e12467

Parra NS, Hoteit MA, Rattan P, Abt P, Mahmud N. Trends in candidate HCV NAT+ listing and associated impacts on liver transplantation waitlist outcomes , Am J Transplant: 2024

Tabrizian P, Holzner M, Ajmera V, Kim AK, Zhou K, Schnickel GT, Torosian K, Hoteit M, Marino R, Li M, Yao F, Florman SS, Schwartz ME, Mehta N Intention-to-treat outcomes of patients with hepatocellular carcinoma receiving immunotherapy before liver transplant: the multicenter VITALITY study , J Hepatol: 2024